Qingdao Haier Biomedical Co.,Ltd (SHA:688139)
China flag China · Delayed Price · Currency is CNY
33.80
+2.21 (7.00%)
At close: Oct 23, 2026

SHA:688139 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
996.29843.83901.231,269951.78774.39
Trading Asset Securities
671.23447.59877.25651.142,0242,130
Cash & Short-Term Investments
1,6681,2911,7781,9202,9752,904
Cash Growth
23.96%-27.39%-7.39%-35.46%2.45%28.69%
Accounts Receivable
564.25445.28352.76208.35192.17136.29
Other Receivables
8.68.058.567.473.9932
Receivables
572.85453.33361.32215.82196.16168.29
Inventory
333.76345.47334.74248.02270.55345.75
Prepaid Expenses
--0.142.561.210.41
Other Current Assets
379.96568.62177.77149.2145.1938.23
Total Current Assets
2,9542,6592,6522,5363,4893,457
Property, Plant & Equipment
933.54923.01915.18862.22802.08464.13
Long-Term Investments
243.32981.39972.711,030371.85358.34
Goodwill
757.57758.24757.87642.68451.3323.45
Other Intangible Assets
330.57360.5402.3367.73312.35241.62
Long-Term Deferred Tax Assets
99.3889.6766.0151.6730.5235.43
Long-Term Deferred Charges
4.975.66.725.695.460.5
Other Long-Term Assets
631.4114.2514.2429.1826.9119.53
Total Assets
5,9555,7925,7875,5265,4894,900

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Accounts Payable
505.15429.38427.6390.98485.06431.57
Accrued Expenses
77.5242.19228.65235.15245.6196.05
Short-Term Debt
10.0110.0110.016.0110.01-
Current Portion of Long-Term Debt
-10----
Current Portion of Leases
-5.015.763.425.481.65
Current Income Taxes Payable
23.8723.6635.2135.828.6848.01
Current Unearned Revenue
101.3170.92151.98111.81232.84362.05
Other Current Liabilities
344.04194.33163.2158.51176.81104.17
Total Current Liabilities
1,0621,0851,022941.661,1841,144
Long-Term Leases
4.924.547.438.6910.674.32
Long-Term Unearned Revenue
51.4326.0823.1728.6232.8832.18
Long-Term Deferred Tax Liabilities
41.1345.8952.5146.9943.5925.9
Other Long-Term Liabilities
6.846.3163.8159.7569.0355.18
Total Liabilities
1,1661,1681,1691,0861,3411,261

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Common Stock
316.49317.95317.95317.95317.95317.07
Additional Paid-In Capital
1,9301,9761,9771,9871,9951,913
Retained Earnings
2,4392,3232,2192,0151,7511,309
Treasury Stock
-183.5-248.68-140.2-99.74-98.07-
Comprehensive Income & Other
2.857.46-2.6910.3753.8984.34
Total Common Equity
4,5044,3764,3724,2314,0213,623
Minority Interest
284.24247.5246.59209.25127.7115.95
Shareholders' Equity
4,7894,6234,6184,4404,1483,639
Total Liabilities & Equity
5,9555,7925,7875,5265,4894,900

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Total Debt
14.9229.5523.218.1126.155.97
Net Cash (Debt)
1,6531,2621,7551,9022,9492,898
Net Cash Growth
24.39%-28.11%-7.73%-35.50%1.76%29.86%
Net Cash Per Share
5.294.035.556.009.289.12
Filing Date Shares Outstanding
311.72311.71314.48315.68316.49317.07
Total Common Shares Outstanding
311.72311.75314.48316.47316.49317.07
Working Capital
1,8921,5731,6301,5942,3042,313
Book Value Per Share
14.4514.0413.9013.3712.7011.43
Tangible Book Value
3,4163,2573,2113,2203,2573,058
Tangible Book Value Per Share
10.9610.4510.2110.1810.299.64
Buildings
-785.74696.63649.88257.73243.72
Machinery
-359.68333.52284.75240.79151.04
Construction In Progress
-54.9795.0370.33389.34130.96